Depression

AMA Moves to Ban Direct-To-Consumer Pharmaceutical Ads

According to the AMA, direct-to-consumer advertising of pharmaceuticals and medical devices drives up health care costs and should be banned. [More…]

Read More
DETAIL

National Depression Screening Day

October 8th is National Depression Screening Day This year commemorates the 25th Annual National Depression Screening Day Screenings in schools Mental health professionals are using screenings as a way to identify potential physical and mental health conditions. Just as a blood pressure screen helps to detect warning signs, a mental health screening provides a quick […]

Read More
DETAIL

Shared Decision Making Tool for Antidepressant Choices

The choice of antidepressant in primary care can directly affect outcomes and quality of care for patients with depression. Faculty at the Mayo Clinic developed the Depression Medication Choice (DMC) encounter decision aid, designed to help patients and clinicians consider the available antidepressants and the extent to which they improved depression and other issues important […]

Read More
DETAIL

Americans Say They View Mental and Physical Health As Equally Important

A recent Harris Poll survey about attitudes toward mental health was conducted on behalf of the Anxiety and Depression Associations of America, American Foundation for Suicide Prevention and the National Alliance for Suicide Prevention. Over 2,000 US adults over 18 responded. Results revealed that “ majority (65%) of U.S. adults has seen a primary care […]

Read More
DETAIL

Primary Care Providers Should Screen For Depression: US Task Force

This week the U.S. Preventive Services Task Force posted a draft recommendation statement and draft evidence review on screening for depression in adults. Both are available for review and public comment from July 28 through August 24, 2015. In this proposal, the Task Force broadens its 2009 recommendation that adults should be screened in doctors’ […]

Read More
DETAIL

Atypical Antipsychotic Shows Promise for New MDD Subtype

New to the diagnosis of major depressive disorder as of DSM-5 is the specifier “with mixed features.” According to DSM-5, “specifiers provide an opportunity to define a more homogeneous subgrouping of individuals with the disorder who share certain features (e.g., major depressive disorder, with mixed features) and to convey information that is relevant to the […]

Read More
DETAIL

Antidepressants Can Improve Cardiovascular Outcomes

A study being presented at the American College of Cardiology meeting this coming weekend reports that patients with moderate to severe depression who took antidepressants alone had a lower risk of death, coronary artery disease and stroke than patients with moderate to severe depression who did not take antidepressant or statin medications. Moderately to severely depressed patients […]

Read More
By R Kennedy | Cardiovascular . Depression
DETAIL

Watching Individual Neurons Respond During Transcranial Magnetic Stimulation

Transcranial magnetic stimulation (TMS) is used to treat refractory major depression. Until now, there was no way of knowing exactly what changes were taking place in the brain as a result of treatment. Duke University neuroscientists and engineers have developed a way to measure the response of an individual neuron to TMS. Measuring neural responses […]

Read More
DETAIL